# FDA Inspection 1062002 - BioCollections Worldwide, Inc. - June 04, 2018

Source: https://www.keypedia.com/records/fda_inspections/biocollections-worldwide-inc/e923fa24-7d91-4afd-afa0-98e07be7d9da
Source feed: FDA_Inspections

> FDA Inspection 1062002 for BioCollections Worldwide, Inc. on June 04, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1062002
- Company Name: BioCollections Worldwide, Inc.
- Inspection Date: 2018-06-04
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1292136 - 2025-11-19](https://www.keypedia.com/records/fda_inspections/biocollections-worldwide-inc/0f9889fb-afd7-45bd-a671-8c052f7e6b93)
- [FDA Inspection 1292136 - 2025-11-19](https://www.keypedia.com/records/fda_inspections/biocollections-worldwide-inc/b9bb3de4-8913-4171-8972-b27c91a13e08)
- [FDA Inspection 842549 - 2013-08-01](https://www.keypedia.com/records/fda_inspections/biocollections-worldwide-inc/4dec89a6-c804-4577-8d4b-30cc758311e2)
- [FDA Inspection 659167 - 2010-04-27](https://www.keypedia.com/records/fda_inspections/biocollections-worldwide-inc/e4981d41-8c3d-4488-95fa-669fb150b269)

Company: https://www.keypedia.com/companies/biocollections-worldwide-inc/e02ac0d8-84ee-408f-94de-d278284072c2

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d